Navigation Links
Avocados may help prevent oral cancer, OSU study shows
Date:9/22/2007

Columbus, Ohio -- Nutrients taken from avocados are able to thwart oral cancer cells, killing some and preventing pre-cancerous cells from developing into actual cancers, according to researchers at Ohio State University.

Researchers found that extracts from Hass avocados kill or stop the growth of pre-cancerous cells that lead to oral cancer. Hass avocados are year-round fruits known for their distinctive bumpy skin that turns from green to purplish-black as they ripen.

While there are more than 500 varieties of avocados grown worldwide, Hass avocados are the most readily available at supermarkets nationwide. Similar research has not been conducted on other varieties of avocados.

The findings are published online in the journal Seminars in Cancer Biology.

Lead author Steven M. D'Ambrosio, a member of the molecular carcinogenesis and chemoprevention program at Ohio State's Comprehensive Cancer Center, also wrote an accompanying editorial for the journal, discussing the cancer-fighting potential of fruits and vegetables. D'Ambrosio collaborated with Haiming Ding in Ohio State's College of Medicine.

Studies have long associated the consumption of fruits and vegetables with a reduced risk for various types of human cancer. The protective effect is attributed to the high levels of phytonutrients or phytochemicals plant compounds thought to have health-protecting qualities that are often found in dark colored fruits and vegetables.

"As far as we know, this is the first study of avocados and oral cancer," says D'Ambrosio. "We think these phytochemicals either stop the growth of precancerous cells in the body or they kill the precancerous cells without affecting normal cells. Our study focuses on oral cancer, but the findings might have implications for other types of cancer. These are preliminary findings, and more research is needed."

D'Ambrosio, who collaborated with researchers in Ohio State's College of Pharmacy, found that phytochemicals extracted from avocados target multiple signaling pathways and increase the amount of reactive oxygen within the cells, leading to cell death in pre-cancerous cell lines. But the phytochemicals did not harm normal cells.

"These studies suggest that individual and a combination of phytochemicals from the avocado fruit may offer an advantageous dietary strategy in cancer prevention," says Ding, who is a member of the division of radiobiology, department of radiology.

Avocados are chock-full of beneficial antioxidants and phytonutrients, including vitamin C, folate, vitamin E, fiber and unsaturated fats. They are naturally sodium-free, contain no trans fats and are low in saturated fat, making them a healthy addition to any diet, D'Ambrosio says.

"The future is ripe for identifying fruits and vegetables and individual phytonutrients with cancer preventing activity," writes D'Ambrosio in the journal's editorial. "As we identify the molecular mechanisms and targets by which individual phytonutrients prevent cancer, we may be able to improve upon nature by formulating phytonutrient cocktails for specific cancers and individual susceptibility and risk."


'/>"/>

Contact: Eileen Scahill
Eileen.Scahill@osumc.edu
614-293-3737
Ohio State University
Source:Eurekalert

Related biology news :

1. A comprehensive response to HIV could prevent 10 million AIDS deaths in Africa by 2020
2. NYCs First Rapid HIV Drug-resistant AIDS Case Prompts Call to Step Up HIV Prevention
3. Antiretroviral therapy may prevent excess risk of some cancers in people with HIV
4. Rare surgery performed to remove pancreas, prevent diabetes
5. Yeast Network Prevents Damage By Oxygen Radicals
6. Undesirable expatriates: Preventing the spread of invasive animals
7. Protein prevents detrimental immune effects of bacterial sepsis
8. Active Vaccine Prevents Mice From Developing Prion Disease
9. Understanding how bacteria communicate may help scientists prevent disease
10. Antiretroviral Therapy May Prevent HIV Transmission From Breastfeeding Mothers To Infants
11. Does vitamin C help prevent or treat the common cold? Maybe not, after all.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/6/2017)... 6, 2017 Forecasts by Product ... Readers, by End-Use (Transportation & Logistics, Government & Public ... & Fossil Generation Facility, Nuclear Power), Industrial, Retail, Business ... Are you looking for a definitive report on ... ...
(Date:4/4/2017)... , April 4, 2017   EyeLock LLC , ... that the United States Patent and Trademark Office (USPTO) ... covers the linking of an iris image with a ... and represents the company,s 45 th issued patent. ... is very timely given the multi-modal biometric capabilities that ...
(Date:3/30/2017)... March 30, 2017 Trends, opportunities and forecast ... behavioral), by technology (fingerprint, AFIS, iris recognition, facial recognition, ... others), by end use industry (government and law enforcement, ... and banking, and others), and by region ( ... Asia Pacific , and the Rest ...
Breaking Biology News(10 mins):
(Date:4/27/2017)... ... April 27, 2017 , ... Mitotech S.A, a Luxembourg based clinical stage biotechnology ... patients. LHON is a rare devastating genetic disease that leads to a sudden and ... group of 20 patients carrying 11778, 14484 and 3460 mutations and having experienced the ...
(Date:4/27/2017)... ... April 27, 2017 , ... Sierra Instruments ... based on capillary thermal mass flow technology provide exponentially more accurate mass flow ... Over 80% of all industrial processes—such as those involving chemical reactions, combustion, respiration, ...
(Date:4/27/2017)... -- Pendant Biosciences, Inc. (formerly Nanoferix, Inc.), a privately-held advanced ... technologies, today announced that it has been accepted into ... . Shawn Glinter , Founder ... are excited to become part of the JLABS @ ... to be the first Tennessee -based ...
(Date:4/26/2017)... ... April 26, 2017 , ... Led by ex-FDA official Peggy ... comes to Tampa, San Francisco and Boston in 2017. The 2016 sold-out ... such as Pfizer Inc., Teva Pharmaceuticals, Advaxis, Inc., Ocular Therapeutix Inc., Cell Culture ...
Breaking Biology Technology: